Purdue Researchers Advance Tech With Trask Funding
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowSix researchers from Purdue University have received a total of more than $200,000 from the Trask Innovation Fund to help their labs commercialize their innovations. The fund, which supports projects that advance the commercial value of Purdue intellectual property, makes awards twice a year to assist faculty and staff.
The university says there are three fund tracks: Innovation Sparks for Life Science, Innovation Sparks for Physical Sciences, and Commercialization Partner Spark.
“Even during a global pandemic, researchers created many technologies worthy of OTC’s investment to develop solutions through the Purdue commercialization ecosystem and Purdue’s growing Discovery Park District,” said Abhijit Karve, director of business development for OTC.
Purdue researchers receiving funding for the round include:
- Jean Chmielewski, cell penetrating antibacterial peptides for treatment of serious lung infections
- Arun Bhunia, authentication of listeria adhesion protein (LAP)-mediated drug delivery across the epithelial barrier
- Na Lu, prototyping piezoelectric sensing device for real-time concrete strength monitoring
- Pedro Irazoqui, a wearable alerting device for monitoring impending SUDEP risk through multiple biomarkers
- Paul Robinson, handheld device for real-time detection of pathogens, toxins and contaminating chemicals for biodefense and food analysis
- Jeffrey Youngblood, processing of near-minimum viable product prototype for biodegradable packaging from cellulose nanofibrils
Purdue says inventors have until February 19 to apply for funding through the fund.
You can learn more about the projects and other Purdue technologies by clicking here.